Cite
HARVARD Citation
Heineman, T. et al. (n.d.). Analysis of a Phase 2b Study of GEN-003, a Genital Herpes Immunotherapy, Showed Significant Reductions in Viral Shedding and Lesion Rate Vs Placebo. Open forum infectious diseases. p. S59. [Online].